Abstract
We have previously described an autoantibody-catalyzed hydrolysis of vasoactive intestinal peptide (VIP), a 28-amino acid neuropeptide with airway smooth muscle relaxant and anti-inflammatory properties. 1 Paul S Volle DJ Beach CM et al. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science. 1989; 244: 1158-1162 Crossref PubMed Scopus (386) Google Scholar Catalytic antibodies can be expected, by definition, to achieve more efficient inactivation of VIP than antibodies that bind the peptide stoichiometrically. Our aims here were the characterization of catalytic autoantibodies to VIP in asthma; and molecular cloning of catalytic anti-VIP antibody.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.